This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
March 9-11, 2026
San Diego Convention CenterSan Diego, CA, USA
BOOK NOW
Menu
BOOK NOW
keyboard_arrow_right

Tuesday March 10 - PT (Pacific Time, GMT-08:00)

keyboard_arrow_leftSearch & Filter
close
Tuesday March 10 - PT (Pacific Time, GMT-08:00)
close
Showing 3 of 3 Streams
8:55am - 9:00am
Chairperson's Opening Remarks: Cell Line Development & Engineering
8:55am - 9:00am
Chairperson's Opening Remarks: Cell Culture & Upstream Processing
10:00am - 10:30am
Improve Bioreactor Productivity by Controlling Cell Retention Device Temperature in Perfusion Systems
  • Prasad Pathange - Senior Manager, Bayer U.S.
8:55am - 9:00am
Chairperson's Opening Remarks: Cell & Gene Therapy Production & Commercialization
9:00am - 9:30am
Cell & Gene Therapy State of the Industry
9:30am - 10:00am
Cell & Gene Therapy State of the Industry
Showing 1 of 1 Streams
10:30am - 11:15am
Morning Networking Break In the Exhibition Hall
Showing 1 of 1 Streams
11:45am - 12:15pm
Panel Discussion: Future Directions – Making Cell & Gene Therapies More Accessible and Attractive

A forward-looking discussion on how manufacturing innovation, digitalization, and improved supply chains can expand patient access and to viable business cases.

Showing 1 of 1 Streams
12:45pm - 2:00pm
Luncheon in the Exhibition Hall
Showing 3 of 3 Streams
2:00pm - 2:30pm
Developing an Improved Cell Line Development Platform for the Production of Complex Multi-Specific Antibodies
  • Hui-Lan Hu - Associate Principal Scientist, AstraZeneca
2:00pm - 2:30pm
Leveraging Agentic Systems to Build a High Quality Digital Cell Culture SME Companion
  • Yuxin Liu - Scientist, Cell Culture Platform, Sanofi
2:00pm - 2:30pm
Improving Efficiency of Cell Therapy Manufacturing Through Full Automation
  • Mahesh Bule - Associate Director, Kite Pharma a Gilead Company
  • Nate Freund - Director, Kite Pharma (Gilead)
2:30pm - 3:00pm
End-to-End Process Development for Autologous CAR-T Cells: Early-Phase Concepts to Late-Stage Manufacturing
  • Carlos Arbelaez - Associate Director, Johnson & Johnson
Showing 1 of 1 Streams
3:30pm - 4:15pm
Afternoon Networking Break In the Exhibition Hall
Showing 4 of 4 Streams
5:15pm - 5:45pm
Panel Discussion: Aligning Cell Line Innovation with Product Lifecycle Needs

Industry and regulatory experts will address how CLD can be designed to anticipate lifecycle changes, comparability, and commercial scalability, with emphasis on drug substance and drug product integration.

4:45pm - 5:15pm
Adaptive Process Control Using Biocapacitance Probes in Mammalian Fed-Batch Cell Culture for Improved Process Robustness from Bench-top to Pilot Scale
  • Cindy Chelius, Ph.D. - Senior Scientist, Upstream Bioprocess Development, Global Product Development & Supply, Bristol Myers Squibb
4:15pm - 4:45pm
Assessment of Mass Spectrometry Platforms and Software for Host Cell Protein Analysis
  • Jing Wang - Senior Scientist, Regeneron
4:15pm - 4:45pm
Analytical Strategy to Ensure the Quality and Consistency in Cell Products
  • Develop risk-based and science-based analytical control strategy
  • Considerations for assay development, qualification and validation
  • Considerations for stability and shelf-life studies
  • Common pitfalls & how to avoid them


  • Jie Wei - Director of Bioanalytical Sciences, Tr1x, Inc.
Showing 1 of 1 Streams
5:45pm - 7:15pm
Networking Reception in Exhibit Hall
Monday March 9
NextWednesday March 11
Filter
Streams
Formats
Choose Day